David Taber to Liver Neoplasms
This is a "connection" page, showing publications David Taber has written about Liver Neoplasms.
Connection Strength
0.812
-
Incidence and risk factors of hepatocellular carcinoma after orthotopic liver transplantation. Surgery. 2017 03; 161(3):830-836.
Score: 0.404
-
Racial disparity outcomes in patients undergoing hepatectomy: is baseline kidney function a potential explanation? Prog Transplant. 2015 Sep; 25(3):257-62.
Score: 0.373
-
Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer. Clin Cancer Res. 1998 Apr; 4(4):929-34.
Score: 0.028
-
Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study. J Clin Oncol. 2000 Jan; 18(2):371-5.
Score: 0.008